Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Harvard Bioscience (HBIO) Operating Expenses (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Operating Expenses for 16 consecutive years, with $12.5 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 10.99% to $12.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $98.5 million through Dec 2025, up 61.52% year-over-year, with the annual reading at $98.5 million for FY2025, 61.52% up from the prior year.
  • Operating Expenses for Q4 2025 was $12.5 million at Harvard Bioscience, up from $11.8 million in the prior quarter.
  • The five-year high for Operating Expenses was $61.9 million in Q1 2025, with the low at $11.8 million in Q3 2025.
  • Average Operating Expenses over 5 years is $17.8 million, with a median of $15.8 million recorded in 2021.
  • The sharpest move saw Operating Expenses decreased 27.49% in 2023, then soared 262.75% in 2025.
  • Over 5 years, Operating Expenses stood at $17.9 million in 2021, then decreased by 8.8% to $16.3 million in 2022, then dropped by 1.52% to $16.0 million in 2023, then decreased by 12.73% to $14.0 million in 2024, then decreased by 10.99% to $12.5 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $12.5 million, $11.8 million, and $12.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.